Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dainippon presents broad-spectrum antiemetic agent

March 24, 1997

New advances in Alzheimer's disease treatment, prevention and diagnosis

March 24, 1997

Bay-x-3702: Neuroprotective 5-HT1A receptor agonist from Bayer

March 24, 1997

Dual NOS/COX inhibitors claimed by SCRAS

March 24, 1997

New salts of known antimigraine agent from Glaxo Wellcome

March 24, 1997

5-HT1A antagonists from American Home Products

March 24, 1997

SCRAS describes galanthamine derivatives

March 24, 1997

Quadramet enters phase I for arthritis

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

3-D structure of adenylyl cyclase core determined

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...